To hear about similar clinical trials, please enter your email below

Trial Title: Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer

NCT ID: NCT02085031

Condition: Stomach Neoplasms
Minimally Invasive Surgery
Anastomosis

Conditions: Official terms:
Stomach Neoplasms

Conditions: Keywords:
Roux-en-Y Anastomosis
laparoscopic surgery
minilaparotomy
stomach neoplasms

Study type: Interventional

Study phase: Phase 2

Overall status: Unknown status

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Procedure
Intervention name: Intracorporeal Roux-en-Y esophagojejunostomy
Description: During totally laparoscopic total gastrectomy, Roux-en-Y esophagojejunostomy intracorporeally using a transorally inserted anvil (OrVil™) will be performed.
Arm group label: Intracorporeal Roux-en-Y esophagojejunostomy

Intervention type: Procedure
Intervention name: Extracorporeal Roux-en-Y esophagojejunostomy
Description: During laparoscopic total gastrectomy, Roux-en-Y esophagojejunostomy extracorporeally using a transabdominally inserted anvil will be performed.
Arm group label: Extracorporeal Roux-en-Y esophagojejunostomy

Summary: - To date, Roux-en-Y esophagojejunostomy transabdominal extracorporeally by circular stapler was the most common used method during laparoscopy-assisted total gastrectomy for gastric cancer, even though it was not totally laparoscopic surgery in which intracorporeal anastomosis should be performed. - To gain potential clinical benefits from a smaller length of minilaparotomy and an easier anastomosis technique than extracorporeal anastomosis, intracorporeal Roux-en-Y anastomosis using a transorally inserted anvil (OrVil™) during totally laparoscopic total gastrectomy was adopted by experienced surgeons recently. - However, the safety of intracorporeal Roux-en-Y esophagojejunostomy using a transorally inserted anvil (OrVil™) has not yet been evaluated. Thus, the study comparing the safety of intracorporeal versus extracorporeal Roux-en-Y esophagojejunostomy by circular stapler based on a well designed randomized controlled trial is needed.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Age from over 18 to under 75 years - Primary gastric adenocarcinoma confirmed pathologically by endoscopic biopsy - Tumor located at middle or upper third of stomach while laparoscopic total gastrectomy is the planning surgery - Tumor invasion is less than 3cm above the esophagogastric junction - Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale - ASA (American Society of Anesthesiology) score class I, II, or III - Written informed consent Exclusion Criteria: - Women during pregnancy or breast-feeding - Severe mental disorder - History of previous upper abdominal surgery (except laparoscopic cholecystectomy) - Conversion to open surgery before reconstruction

Gender: All

Minimum age: 19 Years

Maximum age: 74 Years

Healthy volunteers: No

Locations:

Facility:
Name: Nanfang Hospital, Southern Medical University

Address:
City: Guangzhou
Zip: 510-515
Country: China

Status: Recruiting

Contact:
Last name: Guoxin Li, M.D., Ph.D.

Phone: +86-138-0277-1450
Email: gzliguoxin@163.com

Contact backup:
Last name: Yanfeng Hu, M.D.

Phone: +86-136-3249-4551
Email: huyanfenger@vip.tom.com

Investigator:
Last name: Guoxin Li, M.D.,Ph.D.
Email: Principal Investigator

Investigator:
Last name: Jiang Yu, M.D., Ph.D.
Email: Sub-Investigator

Investigator:
Last name: Yanfeng Hu, M.D.
Email: Sub-Investigator

Investigator:
Last name: Tingyu Mou, M.D.
Email: Sub-Investigator

Investigator:
Last name: Zhenwei Deng, M.D.
Email: Sub-Investigator

Start date: April 2014

Completion date: December 2015

Lead sponsor:
Agency: Nanfang Hospital, Southern Medical University
Agency class: Other

Source: Nanfang Hospital, Southern Medical University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT02085031
http://www.fimmu.com/index_com.html
http://www.nfyy.com
http://www.caca.org.cn

Login to your account

Did you forget your password?